Renin-Angiotensin System Inhibitors and the COVID-19 Pandemic.

Muchaili, Lweendo; Mweene, Bislom C; Masenga, Sepiso K

Muchaili, Lweendo; Mweene, Bislom C; Masenga, Sepiso K.

Muchaili L; HAND Research Group, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Mweene BC; HAND Research Group, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Masenga SK; HAND Research Group, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.

Am J Hypertens ; 36(7): 360-362, 2023 06 15.

Article in English | MEDLINE | ID: covidwho-2273091

Subject(s)

COVID-19; Humans; Renin-Angiotensin System/drug effects; Pandemics; SARS-CoV-2; Peptidyl-Dipeptidase A/metabolism; Antihypertensive Agents/pharmacology

Keywords

2; ACE2; COVID-19 pandemic; SARS-COV; blood pressure; cardiovascular disease; hypertension; renin-angiotensin system inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Am J Hypertens Journal subject: Vascular Diseases Year: 2023 Document Type: Article Affiliation country: Ajh

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google